(Q36311981)

13 August 2017

1 reference

title

Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation (English)

1 reference

head and neck squamous cell carcinoma

13 August 2017

1 reference

2

Evandro de Azambuja

0 references

author name string

Phillipe Lothaire

1

1 reference

13 August 2017

Didier Dequanter

3

1 reference

13 August 2017

Yassine Lalami

4

1 reference

13 August 2017

Christos Sotiriou

5

1 reference

13 August 2017

Guy Andry

6

1 reference

13 August 2017

Gilberto Castro

7

1 reference

13 August 2017

Ahmad Awada

8

1 reference

13 August 2017

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

28

1 reference

13 August 2017

256-269

1 reference

13 August 2017

3

1 reference

The use of genetic markers in the clinical care of patients with head and neck cancer

13 August 2017

1 reference

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

21 January 2018

1 reference

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC).

21 January 2018

1 reference

7 January 2021

Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma

1 reference

7 January 2021

Prognostic relevance of molecular markers of oral cancer--a review

1 reference

7 January 2021

Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma

1 reference

7 January 2021

Targeting epidermal growth factor receptor in head and neck cancer

1 reference

7 January 2021

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

1 reference

7 January 2021

Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.

1 reference

7 January 2021

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

7 January 2021

Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas

1 reference

7 January 2021

Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis

1 reference

7 January 2021

C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors.

1 reference

7 January 2021

Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer.

1 reference

7 January 2021

Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes

1 reference

7 January 2021

Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome

1 reference

7 January 2021

Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression

1 reference

7 January 2021

Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma

1 reference

7 January 2021

Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma

1 reference

7 January 2021

p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx

1 reference

7 January 2021

Retrospective analysis of Ki-67 antigen expression in paraffin tissue blocks of laryngeal squamous cell carcinoma

1 reference

7 January 2021

Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma

1 reference

7 January 2021

Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index

1 reference

7 January 2021

Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia

1 reference

7 January 2021

Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations.

1 reference

7 January 2021

Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study

1 reference

7 January 2021

P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy

1 reference

7 January 2021

p53 and Ki-67 as markers of radioresistance in head and neck carcinoma

1 reference

7 January 2021

bcl-2 expression in head and neck cancer: an enigmatic prognostic marker

1 reference

7 January 2021

Clinicopathologic significance of bcl-2 expression in the surgical treatment of oral tongue carcinoma

1 reference

7 January 2021

Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck

1 reference

7 January 2021

A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status

1 reference

7 January 2021

Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis

1 reference

7 January 2021

Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue.

1 reference

7 January 2021

Localization of Fas antigen in oral squamous cell carcinoma

1 reference

7 January 2021

Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck

1 reference

7 January 2021

Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma

1 reference

7 January 2021

Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines

1 reference

7 January 2021

Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activities from a lymph node metastasis

1 reference

7 January 2021

Reduced expression of p27 is correlated with progression in precancerous lesions of the larynx

1 reference

7 January 2021

Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma

1 reference

7 January 2021

Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma

1 reference

7 January 2021

The p53 network in head and neck cancer

1 reference

7 January 2021

p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.

1 reference

7 January 2021

The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors

1 reference

7 January 2021

Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma

1 reference

7 January 2021

Prognostic factors in laryngeal carcinoma: the role of apoptosis, p53, proliferation (Ki-67) and angiogenesis

1 reference

7 January 2021

p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx

1 reference

7 January 2021

p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma

1 reference

7 January 2021

Detection of p53 protein in oropharyngeal carcinoma. Prognostic implications

1 reference

7 January 2021

P53 overexpression in head and neck carcinoma and radiotherapy results

1 reference

7 January 2021

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma

1 reference

7 January 2021

Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx.

1 reference

7 January 2021

Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer

1 reference

7 January 2021

p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy

1 reference

7 January 2021

TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent

1 reference

7 January 2021

P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.

1 reference

7 January 2021

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

1 reference

7 January 2021

p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck

1 reference

7 January 2021

Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma

1 reference

7 January 2021

Tumor markers in squamous cell carcinoma of the head and neck: clinical effectiveness and prognostic value

1 reference

7 January 2021

A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients.

1 reference

7 January 2021

Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.

1 reference

7 January 2021

Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis

1 reference

7 January 2021

Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma

1 reference

7 January 2021

Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma

1 reference

7 January 2021

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.

1 reference

7 January 2021

Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.

1 reference

7 January 2021

Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status

1 reference

7 January 2021

Vascular endothelial growth factor expression in head and neck squamous cell carcinoma

1 reference

7 January 2021

Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma

1 reference

7 January 2021

Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy

1 reference

7 January 2021

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

1 reference

7 January 2021

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas

1 reference

7 January 2021

Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma

1 reference

7 January 2021

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

1 reference

7 January 2021

Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness

1 reference

7 January 2021

Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma

1 reference

7 January 2021

Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma

1 reference

7 January 2021

Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas

1 reference

7 January 2021

Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients

1 reference

7 January 2021

Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas

1 reference

7 January 2021

Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma

1 reference

7 January 2021

Molecular profiling of head and neck tumors

1 reference

7 January 2021

Array CGH technologies and their applications to cancer genomes

1 reference

7 January 2021

Historical prospective of human cytogenetics: from microscope to microarray

1 reference

7 January 2021

Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis

1 reference

7 January 2021

Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis

1 reference

7 January 2021

Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation

1 reference

7 January 2021

Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis.

1 reference

7 January 2021

Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and CDNA microarray

1 reference

7 January 2021

Current applications of microarrays in head and neck cancer research

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20326

1 reference

13 August 2017

1 reference